{"entity":{"type":"insider","cik":"0001437152","url":"/insider/0001437152","json_url":"/insider/0001437152.json","name":"Valentine Karen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":21,"first":"2009-07-17","last":"2021-01-20","span_basis":"filed_date"},"name_variants":[{"name":"Valentine Karen","source":"filing","n_filings":21,"first_seen":"2009-07-17","last_seen":"2021-01-20"}],"transactions":[{"id":4790135,"accession":"0001562180-21-000392","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-000392","line_url":"/filing/0001562180-21-000392","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17203.0,"shares_display":"17,203","price_per_share":33.97445961750857,"price_display":"33.97","price_state":"stated","total_value":584462.6288,"total_display":"584,462.63","total_whole":"584,463","shares_owned_after":8430.0,"shares_owned_after_display":"8,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-20","scope":"insider","n_lines":3},{"id":2995689,"accession":"0001562180-20-003453","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-20-003453","line_url":"/filing/0001562180-20-003453#line-5","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12566.0,"shares_display":"12,566","price_per_share":40.1,"price_display":"40.10","price_state":"stated","total_value":503896.6,"total_display":"503,896.60","total_whole":"503,897","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-06","filed_date":"2020-05-07","scope":"insider"},{"id":2995683,"accession":"0001562180-20-003453","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-003453","line_url":"/filing/0001562180-20-003453#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4744.0,"shares_display":"4,744","price_per_share":40.0121,"price_display":"40.01","price_state":"stated","total_value":189817.4024,"total_display":"189,817.40","total_whole":"189,817","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-07","scope":"insider"},{"id":2269915,"accession":"0001562180-20-003207","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-003207","line_url":"/filing/0001562180-20-003207#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":40.13,"price_display":"40.13","price_state":"stated","total_value":16052.0,"total_display":"16,052.00","total_whole":"16,052","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-27","filed_date":"2020-04-29","scope":"insider"},{"id":2460429,"accession":"0001562180-20-003096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-003096","line_url":"/filing/0001562180-20-003096#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":789.0,"shares_display":"789","price_per_share":33.6503,"price_display":"33.65","price_state":"stated","total_value":26550.0867,"total_display":"26,550.09","total_whole":"26,550","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-20","filed_date":"2020-04-22","scope":"insider"},{"id":3225154,"accession":"0001562180-20-003062","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-20-003062","line_url":"/filing/0001562180-20-003062#line-5","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":35.191,"price_display":"35.19","price_state":"stated","total_value":80939.3,"total_display":"80,939.30","total_whole":"80,939","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-17","filed_date":"2020-04-20","scope":"insider"},{"id":3225145,"accession":"0001562180-20-003062","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-20-003062","line_url":"/filing/0001562180-20-003062","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2998.0,"shares_display":"2,998","price_per_share":33.56814022681788,"price_display":"33.57","price_state":"stated","total_value":100637.2844,"total_display":"100,637.28","total_whole":"100,637","shares_owned_after":1043.0,"shares_owned_after_display":"1,043","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-16","filed_date":"2020-04-20","scope":"insider","n_lines":2},{"id":2499157,"accession":"0001562180-20-002991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-002991","line_url":"/filing/0001562180-20-002991#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":635.0,"shares_display":"635","price_per_share":35.0177,"price_display":"35.02","price_state":"stated","total_value":22236.2395,"total_display":"22,236.24","total_whole":"22,236","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-09","filed_date":"2020-04-13","scope":"insider"},{"id":3189695,"accession":"0001562180-20-002396","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-002396","line_url":"/filing/0001562180-20-002396","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":617.0,"shares_display":"617","price_per_share":32.03120307941653,"price_display":"32.03","price_state":"stated","total_value":19763.2523,"total_display":"19,763.25","total_whole":"19,763","shares_owned_after":130.0,"shares_owned_after_display":"130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-11","scope":"insider","n_lines":3},{"id":3104576,"accession":"0001562180-20-001250","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-20-001250","line_url":"/filing/0001562180-20-001250#line-5","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4473.0,"shares_display":"4,473","price_per_share":35.0679,"price_display":"35.07","price_state":"stated","total_value":156858.7167,"total_display":"156,858.72","total_whole":"156,859","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-14","scope":"insider"},{"id":3104566,"accession":"0001562180-20-001250","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-001250","line_url":"/filing/0001562180-20-001250#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":35.018,"price_display":"35.02","price_state":"stated","total_value":52527.0,"total_display":"52,527.00","total_whole":"52,527","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-12","filed_date":"2020-02-14","scope":"insider"},{"id":2269674,"accession":"0001562180-20-001122","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-001122","line_url":"/filing/0001562180-20-001122#line-4","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8550.0,"shares_display":"8,550","price_per_share":35.03,"price_display":"35.03","price_state":"stated","total_value":299506.5,"total_display":"299,506.50","total_whole":"299,507","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-12","scope":"insider"},{"id":2238915,"accession":"0001562180-20-001187","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-20-001187","line_url":"/filing/0001562180-20-001187#line-5","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8550.0,"shares_display":"8,550","price_per_share":35.03,"price_display":"35.03","price_state":"stated","total_value":299506.5,"total_display":"299,506.50","total_whole":"299,507","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-13","scope":"insider"},{"id":2269666,"accession":"0001562180-20-001122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-001122","line_url":"/filing/0001562180-20-001122#line-2","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14096.0,"shares_display":"14,096","price_per_share":33.51,"price_display":"33.51","price_state":"stated","total_value":472356.96,"total_display":"472,356.96","total_whole":"472,357","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-12","scope":"insider"},{"id":2238908,"accession":"0001562180-20-001187","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-20-001187","line_url":"/filing/0001562180-20-001187#line-3","is_derivative":false,"issuer_cik":"0001434418","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001434418","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14096.0,"shares_display":"14,096","price_per_share":33.51,"price_display":"33.51","price_state":"stated","total_value":472356.96,"total_display":"472,356.96","total_whole":"472,357","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-13","scope":"insider"},{"id":5365501,"accession":"0001288123-17-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-17-000040","line_url":"/filing/0001288123-17-000040#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8358.0,"shares_display":"8,358","price_per_share":3.4603,"price_display":"3.46","price_state":"stated","total_value":28921.1874,"total_display":"28,921.19","total_whole":"28,921","shares_owned_after":101521.0,"shares_owned_after_display":"101,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2017-12-14","scope":"insider"},{"id":6833512,"accession":"0001288123-14-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-14-000007","line_url":"/filing/0001288123-14-000007#line-1","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP General Counsel)","role_mark":"O","role_mark_label":"Officer (VP General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2850.0,"shares_display":"2,850","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":9975.0,"total_display":"9,975.00","total_whole":"9,975","shares_owned_after":51534.0,"shares_owned_after_display":"51,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-23","filed_date":"2014-01-24","scope":"insider"},{"id":9038419,"accession":"0001288123-11-000098","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001288123-11-000098","line_url":"/filing/0001288123-11-000098#line-3","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7605.0,"shares_display":"7,605","price_per_share":1.98,"price_display":"1.98","price_state":"stated","total_value":15057.9,"total_display":"15,057.90","total_whole":"15,058","shares_owned_after":1191.0,"shares_owned_after_display":"1,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-29","filed_date":"2011-12-29","scope":"insider"},{"id":9038418,"accession":"0001288123-11-000098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-11-000098","line_url":"/filing/0001288123-11-000098#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1301.0,"shares_display":"1,301","price_per_share":2.09,"price_display":"2.09","price_state":"stated","total_value":2719.09,"total_display":"2,719.09","total_whole":"2,719","shares_owned_after":8796.0,"shares_owned_after_display":"8,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-28","filed_date":"2011-12-29","scope":"insider"},{"id":9038417,"accession":"0001288123-11-000098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-11-000098","line_url":"/filing/0001288123-11-000098#line-1","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2169.0,"shares_display":"2,169","price_per_share":2.14,"price_display":"2.14","price_state":"stated","total_value":4641.66,"total_display":"4,641.66","total_whole":"4,642","shares_owned_after":10097.0,"shares_owned_after_display":"10,097","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-27","filed_date":"2011-12-29","scope":"insider"},{"id":9017586,"accession":"0001288123-11-000093","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001288123-11-000093","line_url":"/filing/0001288123-11-000093#line-3","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":608.0,"shares_display":"608","price_per_share":2.1973,"price_display":"2.20","price_state":"stated","total_value":1335.9584,"total_display":"1,335.96","total_whole":"1,336","shares_owned_after":12266.0,"shares_owned_after_display":"12,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-23","filed_date":"2011-12-23","scope":"insider"},{"id":9017585,"accession":"0001288123-11-000093","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-11-000093","line_url":"/filing/0001288123-11-000093#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1177.0,"shares_display":"1,177","price_per_share":2.1903,"price_display":"2.19","price_state":"stated","total_value":2577.9831,"total_display":"2,577.98","total_whole":"2,578","shares_owned_after":12874.0,"shares_owned_after_display":"12,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-22","filed_date":"2011-12-23","scope":"insider"},{"id":9017584,"accession":"0001288123-11-000093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-11-000093","line_url":"/filing/0001288123-11-000093#line-1","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP, General Counsel)","role_mark":"O","role_mark_label":"Officer (VP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, General Counsel","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2348.0,"shares_display":"2,348","price_per_share":2.238,"price_display":"2.24","price_state":"stated","total_value":5254.824,"total_display":"5,254.82","total_whole":"5,255","shares_owned_after":14051.0,"shares_owned_after_display":"14,051","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2011-12-23","scope":"insider"},{"id":7652402,"accession":"0001288123-10-000073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-10-000073","line_url":"/filing/0001288123-10-000073#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":2450.0,"total_display":"2,450.00","total_whole":"2,450","shares_owned_after":56491.0,"shares_owned_after_display":"56,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-27","filed_date":"2010-10-28","scope":"insider"},{"id":7204057,"accession":"0001288123-10-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-10-000064","line_url":"/filing/0001288123-10-000064#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3333.0,"shares_display":"3,333","price_per_share":0.9139,"price_display":"0.91","price_state":"stated","total_value":3046.0287,"total_display":"3,046.03","total_whole":"3,046","shares_owned_after":56491.0,"shares_owned_after_display":"56,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-14","filed_date":"2010-09-14","scope":"insider"},{"id":7166657,"accession":"0001288123-10-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-10-000021","line_url":"/filing/0001288123-10-000021#line-1","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29039.0,"shares_display":"29,039","price_per_share":0.7578,"price_display":"0.76","price_state":"stated","total_value":22005.7542,"total_display":"22,005.75","total_whole":"22,006","shares_owned_after":51491.0,"shares_owned_after_display":"51,491","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-16","filed_date":"2010-03-18","scope":"insider"},{"id":9281838,"accession":"0001288123-10-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-10-000011","line_url":"/filing/0001288123-10-000011#line-1","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93789.0,"shares_display":"93,789","price_per_share":0.8534,"price_display":"0.85","price_state":"stated","total_value":80039.5326,"total_display":"80,039.53","total_whole":"80,040","shares_owned_after":80530.0,"shares_owned_after_display":"80,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-20","filed_date":"2010-01-22","scope":"insider"},{"id":7453212,"accession":"0001288123-10-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-10-000007","line_url":"/filing/0001288123-10-000007#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":93789.0,"shares_display":"93,789","price_per_share":0.8534,"price_display":"0.85","price_state":"stated","total_value":80039.5326,"total_display":"80,039.53","total_whole":"80,040","shares_owned_after":80530.0,"shares_owned_after_display":"80,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-20","filed_date":"2010-01-21","scope":"insider"},{"id":5656031,"accession":"0001288123-09-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-09-000058","line_url":"/filing/0001288123-09-000058#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1094.0,"shares_display":"1,094","price_per_share":2.323,"price_display":"2.32","price_state":"stated","total_value":2541.362,"total_display":"2,541.36","total_whole":"2,541","shares_owned_after":80530.0,"shares_owned_after_display":"80,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-11","filed_date":"2009-09-14","scope":"insider"},{"id":5609562,"accession":"0001288123-09-000049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001288123-09-000049","line_url":"/filing/0001288123-09-000049#line-3","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15930.0,"shares_display":"15,930","price_per_share":1.618,"price_display":"1.62","price_state":"stated","total_value":25774.74,"total_display":"25,774.74","total_whole":"25,775","shares_owned_after":78291.0,"shares_owned_after_display":"78,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-16","filed_date":"2009-07-17","scope":"insider"},{"id":5609561,"accession":"0001288123-09-000049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-09-000049","line_url":"/filing/0001288123-09-000049#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001437152","owner_name":"Valentine Karen","owner_display_name":"Valentine Karen","owner_url":"/insider/0001437152","role":"Officer (VP and General Counsel)","role_mark":"O","role_mark_label":"Officer (VP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7753.0,"shares_display":"7,753","price_per_share":1.763,"price_display":"1.76","price_state":"stated","total_value":13668.539,"total_display":"13,668.54","total_whole":"13,669","shares_owned_after":94221.0,"shares_owned_after_display":"94,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-15","filed_date":"2009-07-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":36,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434418","name":"CONSTELLATION PHARMACEUTICALS INC","url":"/issuer/0001434418","role":"Officer","n_filings":10,"first_seen":"2020-02-12","last_seen":"2021-01-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001098972","name":"AGENUS INC","url":"/issuer/0001098972","role":"Officer (Chief Legal Officer)","n_filings":11,"first_seen":"2009-07-17","last_seen":"2017-12-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001437152","retrieved_at":"2026-08-22T21:15:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}